Solifenacin, Levofloxacin or Lornoxicam, Which Is Ideal for Management of Intravesical Instillation BCG Side Effects?

Clinical trial NCT03038321 · UNKNOWN

Trial details

NCT number: NCT03038321
Sponsor: Mansoura University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Non-Muscle-invasive Bladder Cancer (NMIBC)Bacillus Calmette-Guerin (BCG) Cystitis Intra-vesical Instillation

Start date: 2017-02-01
Primary completion: 2017-12-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.